Literature DB >> 18403662

Short-term effects of cardiac resynchronization therapy on sleep-disordered breathing in patients with systolic heart failure.

Tomas Kara1, Miroslav Novak, Jiri Nykodym, Kevin A Bybee, Jaroslav Meluzin, Marek Orban, Zuzana Novakova, Jolana Lipoldova, David L Hayes, Miroslav Soucek, Jiri Vitovec, Virend K Somers.   

Abstract

OBJECTIVES: We evaluated the short-term effect of cardiac resynchronization therapy (CRT) on sleep apnea in patients with systolic heart failure.
BACKGROUND: Sleep-disordered breathing is common in patients with left ventricular systolic dysfunction.
METHODS: Twelve patients (mean [+/-SE] age, 59.6+/-7.8 years; mean left ventricular ejection fraction, 28.0+/-2.8%) with an implanted atrial-synchronized biventricular pacemaker for the treatment of left ventricular systolic dysfunction were selected and studied. Each subject underwent polysomnography on 3 consecutive nights with CRT on the first night, CRT off the second night, and CRT on the third night. Echocardiography was performed prior to each polysomnogram.
RESULTS: The central sleep event index (ie, the number of central sleep apneas [CSAs] and hypopneas per hour of sleep) score was lower with CRT compared to that without CRT (mean central sleep event index score with CRT on, 6.9+/-1.7 events per hour of sleep; mean central sleep event index score with CRT off, 14.3+/-2.9 events per hour of sleep; mean central sleep event index score with CRT on, 8.1+/-1.5 events per hour of sleep; p<0.001). Similarly, the cumulative duration of central sleep events (the number of minutes per hour of sleep during CRT) was one half that observed without CRT (CRT on, 2.8+/-0.7 min per hour of sleep; CRT OFF 6.2+/-1.2 min per hour of sleep; CRT ON 3.1+/-0.7 min per hour of sleep; p<0.001). There was a significant correlation between mitral regurgitant volume and central sleep event index on all three nights (r>or=0.77; p<0.01).
CONCLUSIONS: CRT reduces CSA severity in the short term. This reduction correlated significantly with the CRT-mediated reduction of mitral regurgitation.

Entities:  

Mesh:

Year:  2008        PMID: 18403662     DOI: 10.1378/chest.07-2832

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Overdrive ventricular pacing in pacemaker recipients with permanent atrial fibrillation and sleep apnea.

Authors:  Philippe Bordier; Sylvie Maurice-Tison; Nishi Krishna Ramana
Journal:  J Clin Sleep Med       Date:  2012-06-15       Impact factor: 4.062

Review 2.  Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies.

Authors:  Dominik Linz; Henrik Fox; Thomas Bitter; Jens Spießhöfer; Christoph Schöbel; Erik Skobel; Anke Türoff; Michael Böhm; Martin R Cowie; Michael Arzt; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2016-02-12       Impact factor: 5.460

Review 3.  Sleep-disordered breathing in heart failure: identifying and treating an important but often unrecognized comorbidity in heart failure patients.

Authors:  Rami Khayat; Roy Small; Lisa Rathman; Steven Krueger; Becky Gocke; Linda Clark; Laura Yamokoski; William T Abraham
Journal:  J Card Fail       Date:  2013-06       Impact factor: 5.712

4.  [Sleep-disordered breathing and cardiac resynchronization therapy].

Authors:  A-M Sinha
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-03

Review 5.  Congestive heart failure and central sleep apnea.

Authors:  Scott A Sands; Robert L Owens
Journal:  Crit Care Clin       Date:  2015-07       Impact factor: 3.598

Review 6.  Mechanisms and clinical consequences of untreated central sleep apnea in heart failure.

Authors:  Maria Rosa Costanzo; Rami Khayat; Piotr Ponikowski; Ralph Augostini; Christoph Stellbrink; Marcus Mianulli; William T Abraham
Journal:  J Am Coll Cardiol       Date:  2015-01-06       Impact factor: 24.094

Review 7.  Prevalence and management of central sleep apnea in heart failure patients.

Authors:  Farouk Mookadam; Andrew D Calvin; Virend K Somers
Journal:  Curr Heart Fail Rep       Date:  2008-12

8.  Impact of sacubitril-valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO-SAS study design.

Authors:  Dany Jaffuel; Nicolas Molinari; Philippe Berdague; Atul Pathak; Michel Galinier; Marion Dupuis; Jean-Etienne Ricci; Jean-Pierre Mallet; Arnaud Bourdin; François Roubille
Journal:  ESC Heart Fail       Date:  2018-02-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.